RRM2 and Ewing sarcoma: Finally, to exclude siRNA off-target effects, we generated an Ewing sarcoma cell line that expresses a RRM2 gene, under the control of a doxycycline-inducible promoter, that is resistant to siRNA knockdown (Figure 5H).